In the BioHarmony Drug Report Database

"Preview" Icon

Dopamine

Dopamine, Intropin (dopamine) is a small molecule pharmaceutical. Dopamine was first approved as Dopamine on 1982-01-01. It is used to treat bradycardia, heart block, hypotension, kidney diseases, and low cardiac output amongst others in the USA. The pharmaceutical is active against D(1A) dopamine receptor, D(2) dopamine receptor, D(3) dopamine receptor, D(4) dopamine receptor, and D(1B) dopamine receptor. In addition, it is known to target glucose-dependent insulinotropic receptor, transient receptor potential cation channel subfamily M member 8, transient receptor potential cation channel subfamily V member 1, and ribosyldihydronicotinamide dehydrogenase [quinone].

 

Trade Name

 

Dopamine, Intropin
 

Common Name

 

dopamine
 

ChEMBL ID

 

CHEMBL59
 

Indication

 

bradycardia, heart block, hypotension, kidney diseases, low cardiac output, shock
 

Drug Class

 

Dopaminergics (butopamine type)

Image (chem structure or protein)

Dopamine structure rendering